{"transactions":[{"id":790216,"issuer":{"id":6385,"kind":"organization","name":"WESTWOOD HOLDINGS GROUP INC"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock","published_at":"2026-05-06T21:52:49.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":5780,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11470,"source":{"system":"sec-edgar","filing":"0001930744-26-000002","document":"wk-form4_1778104366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1165002/000193074426000002/wk-form4_1778104366.xml","form_type":"4"}},{"id":812161,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2026-04-08T16:22:35.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":8069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8069},"source":{"system":"sec-edgar","filing":"0001193125-26-146823","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1930744/000119312526146823/ownership.xml","form_type":"4"}},{"id":812160,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2026-04-08T16:22:35.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":7895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2027, subject to the terms of issuance. Such shares remain subject to a deferral election by the Reporting Person in accordance with Treasury Regulation 1.409A-2, and the vested portion thereof will be distributed as shares of common stock following the Reporting Person's separation of service from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2027, subject to the terms of issuance. Such shares remain subject to a deferral election by the Reporting Person in accordance with Treasury Regulation 1.409A-2, and the vested portion thereof will be distributed as shares of common stock following the Reporting Person's separation of service from the Board."}],"balance_after":7895,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7895},"source":{"system":"sec-edgar","filing":"0001193125-26-146823","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1930744/000119312526146823/ownership.xml","form_type":"4"}},{"id":812159,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-08T16:22:35.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":8069,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29290,"source":{"system":"sec-edgar","filing":"0001193125-26-146823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930744/000119312526146823/ownership.xml","form_type":"4"}},{"id":1135732,"issuer":{"id":6385,"kind":"organization","name":"WESTWOOD HOLDINGS GROUP INC"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock","published_at":"2025-05-23T20:36:12.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":5690,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5690,"source":{"system":"sec-edgar","filing":"0001930744-25-000007","document":"wk-form4_1748032560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1165002/000193074425000007/wk-form4_1748032560.xml","form_type":"4"}},{"id":1182212,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2025-04-02T18:39:29.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":9317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9317},"source":{"system":"sec-edgar","filing":"0000950170-25-049174","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1930744/000095017025049174/ownership.xml","form_type":"4"}},{"id":1182211,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2025-04-02T18:39:29.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":8069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance."}],"balance_after":8069,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8069},"source":{"system":"sec-edgar","filing":"0000950170-25-049174","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1930744/000095017025049174/ownership.xml","form_type":"4"}},{"id":1182210,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T18:39:29.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":9317,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21221,"source":{"system":"sec-edgar","filing":"0000950170-25-049174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930744/000095017025049174/ownership.xml","form_type":"4"}},{"id":1552437,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2024-04-02T21:08:14.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":false,"shares":6419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6419},"source":{"system":"sec-edgar","filing":"0000950170-24-040339","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1930744/000095017024040339/ownership.xml","form_type":"4"}},{"id":1552436,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2024-04-02T21:08:14.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":9317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance."}],"balance_after":9317,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9317},"source":{"system":"sec-edgar","filing":"0000950170-24-040339","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1930744/000095017024040339/ownership.xml","form_type":"4"}},{"id":1552435,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T21:08:14.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":true,"shares":6419,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11904,"source":{"system":"sec-edgar","filing":"0000950170-24-040339","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930744/000095017024040339/ownership.xml","form_type":"4"}},{"id":1933002,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2023-04-03T13:38:54.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":false,"shares":5485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":5485},"source":{"system":"sec-edgar","filing":"0001209191-23-022050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123022050/doc4.xml","form_type":"4"}},{"id":1933001,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2023-04-03T13:38:54.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":6419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2024, subject to the terms of issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2024, subject to the terms of issuance."}],"balance_after":6419,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":6419},"source":{"system":"sec-edgar","filing":"0001209191-23-022050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123022050/doc4.xml","form_type":"4"}},{"id":1933000,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":49429,"kind":"person","name":"Murray Katherine","position":1,"cik":"0001930744","reported_name":"Murray Katherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-04-03T13:38:54.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":true,"shares":5485,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5485,"source":{"system":"sec-edgar","filing":"0001209191-23-022050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123022050/doc4.xml","form_type":"4"}}]}